Sale by Anthony Mancini (Chief Global Commercialization Officer)
3,120 shares · @ $132.41 · $413,129
Revolution Medicines, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $163.68
+5.2% in 3d after detection
Post-detection moves
1h
—
1d
+2.5%
3d
+5.2%
7d
+0.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS